{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,7]],"date-time":"2026-03-07T14:51:06Z","timestamp":1772895066670,"version":"3.50.1"},"reference-count":115,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[1999,8,1]],"date-time":"1999-08-01T00:00:00Z","timestamp":933465600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Immunol Res"],"published-print":{"date-parts":[[1999,8]]},"DOI":"10.1007\/bf02786504","type":"journal-article","created":{"date-parts":[[2007,12,20]],"date-time":"2007-12-20T18:10:38Z","timestamp":1198174238000},"page":"15-27","source":"Crossref","is-referenced-by-count":62,"title":["Role of cytokines in pulmonary antimicrobial host defense"],"prefix":"10.1007","volume":"20","author":[{"given":"Borna","family":"Mehrad","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Theodore J.","family":"Standiford","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"BF02786504_CR1","volume-title":"The Basis for Diagnosis and Treatment of Pulmonary Disease","author":"JF Murray","year":"1986","unstructured":"Murray JF: The Normal Lung: The Basis for Diagnosis and Treatment of Pulmonary Disease. Philadelphia, Saunders, 1986."},{"key":"BF02786504_CR2","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/0002-9343(85)90361-4","volume":"78","author":"RA Garibaldi","year":"1985","unstructured":"Garibaldi RA: Epidemiology of community-acquired respiratory tract infections in adults. Incidence, etiology, and impact. Am J Med 1985;78:32\u201337.","journal-title":"Am J Med"},{"key":"BF02786504_CR3","unstructured":"Anonymous. Statistical Abstract of the United States. Washington DC, U. S. Department of Commerce, Bureau of Census, 1988."},{"key":"BF02786504_CR4","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1001\/jama.1996.03530270029027","volume":"275","author":"RW Pinner","year":"1996","unstructured":"Pinner RW, Teutsch SM, Simonsen L, Klug LA, Graber JM, Clarke MJ, et al.: Trends in infectious diseases mortality in the United States. JAMA 1996;275:189\u2013193.","journal-title":"JAMA"},{"key":"BF02786504_CR5","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1093\/clinids\/9.6.1065","volume":"9","author":"SD Holmberg","year":"1987","unstructured":"Holmberg SD, Solomon SL, Blake PA: Health and economic impacts of antimicrobial resistance. Rev Infect Dis 1987;9:1065\u20131078.","journal-title":"Rev Infect Dis"},{"key":"BF02786504_CR6","first-page":"1","volume-title":"Respiratory Infections\u2014Diagnosis and Management","author":"HY Reynolds","year":"1994","unstructured":"Reynolds HY: Normal and defective respiratory host defences; in Pennington, JE (ed): Respiratory Infections\u2014Diagnosis and Management. New York, Raven Press, 1994, pp 1\u201334."},{"key":"BF02786504_CR7","first-page":"833","volume":"69","author":"AE Jackson","year":"1967","unstructured":"Jackson AE, Southern PM, Pierce AK, Fallis BD, Sanford JP: Pulmonary clearance of gram-negative bacilli. J Lab Clin Med 1967; 69:833\u2013841.","journal-title":"J Lab Clin Med"},{"key":"BF02786504_CR8","first-page":"43","volume-title":"Respiratory Infections-Diagnosis and Managment","author":"GB Toews","year":"1994","unstructured":"Toews GB: Pulmonary clearance of infectious agents; inPennington, JE (ed): Respiratory Infections-Diagnosis and Managment. New York, Raven, 1994, pp 43\u201353."},{"key":"BF02786504_CR9","first-page":"234","volume":"56","author":"J Le","year":"1987","unstructured":"Le J, Vilcek J: Tumor necrosis factor and interleukin 1: cytokines with multiple overlapping biological activities. Lab Invest 1987;56: 234\u2013248.","journal-title":"Lab Invest"},{"key":"BF02786504_CR10","first-page":"227","volume":"43","author":"B Beutler","year":"1995","unstructured":"Beutler B: TNF, immunity and inflammatory disease: lessons of the past decade. J Invest Med 1995;43:227\u2013235.","journal-title":"J Invest Med"},{"key":"BF02786504_CR11","first-page":"155","volume":"37","author":"AM Tan","year":"1995","unstructured":"Tan AM, Ferrante A, Goh DH, Roberton DM, Cripps AW: Activation of the neutrophil bactericidal activity for nontypable Haemophilus influenzae by tumor necrosis factor and lymphotoxin. PediatrRes 1995;37:155\u2013159.","journal-title":"PediatrRes"},{"key":"BF02786504_CR12","doi-asserted-by":"crossref","first-page":"8676","DOI":"10.1073\/pnas.89.18.8676","volume":"89","author":"IP Oswald","year":"1992","unstructured":"Oswald IP, Wynn TA, Sher A, James SL: Interleukin 10 inhibits macrophage microbicidal activity by blocking the endogenous production of tumor necrosis factor alpha required as a costimulatory factor for interferon gamma-induced activation. Proc Natl Acad Sci USA 1992;89:8676\u20138680.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BF02786504_CR13","doi-asserted-by":"crossref","first-page":"4529","DOI":"10.4049\/jimmunol.157.10.4529","volume":"157","author":"GB Huffnagle","year":"1996","unstructured":"Huffnagle GB, Toews GB, Burdick MD, Boyd MB, McAllister KS, McDonald RA, et al.: Afferent phase production of TNF-alpha is required for the development of protective T cell immunity to Cryptococcus neoformans. J Immunol 1996;157:4529\u20134536.","journal-title":"J Immunol"},{"key":"BF02786504_CR14","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1164\/ajrccm.150.3.8087341","volume":"150","author":"MS Dehoux","year":"1994","unstructured":"Dehoux MS, Boutten A, Ostinelli J, Seta N, Dombret MC, Crestani B, et al.: Compartmentalized cytokine production within the human lung in unilateral pneumonia. Am J Respir Crit Care Med 1994;150: 710\u2013716.","journal-title":"Am J Respir Crit Care Med"},{"key":"BF02786504_CR15","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1164\/ajrccm.155.2.9032201","volume":"155","author":"T Poll van der","year":"1997","unstructured":"van der Poll T, Keogh CV, Buurman WA, Lowry SF: Passive immunization against tumor necrosis factor -alpha impairs host defense during pneumococcal pneumonia in mice. Am J Respir Crit Care Med 1997; 155:603\u2013608.","journal-title":"Am J Respir Crit Care Med"},{"key":"BF02786504_CR16","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1128\/IAI.65.1.257-260.1997","volume":"65","author":"K Takashima","year":"1997","unstructured":"Takashima K, Tateda K, Matsumoto T, Iizawa Y, Nakao M, Yamaguchi K: Role of tumor necrosis factor alpha in pathogenesis of pneumococcal pneumonia in mice. Infect Immun 1997;65:257\u2013260.","journal-title":"Infect Immun"},{"key":"BF02786504_CR17","doi-asserted-by":"crossref","first-page":"5211","DOI":"10.1128\/IAI.64.12.5211-5218.1996","volume":"64","author":"LL Laichalk","year":"1996","unstructured":"Laichalk LL, Kunkel SL, Strieter RM, Danforth JM, Bailie MB, Standiford TJ: Tumor necrosis factor mediates lung antibacterial host defense in murineKlebsiella pneumonia. Infect Immun 1996; 64:5211\u20135218.","journal-title":"Infect Immun"},{"key":"BF02786504_CR18","doi-asserted-by":"crossref","first-page":"3272","DOI":"10.1128\/IAI.63.9.3272-3278.1995","volume":"63","author":"D Gosselin","year":"1995","unstructured":"Gosselin D, DeSanctis J, Boule M, Skamene E, Matouk C, Radzioch D: Role of tumor necrosis factor alpha in innate resistance to mouse pulmonary infection with Pseudomonas aeruginosa. Infect Immun 1995;63:3272\u20133278.","journal-title":"Infect Immun"},{"key":"BF02786504_CR19","doi-asserted-by":"crossref","first-page":"3253","DOI":"10.1128\/IAI.63.9.3253-3258.1995","volume":"63","author":"JK Brieland","year":"1995","unstructured":"Brieland JK, Remick DG, Freeman PT, Hurley MC, Fantone JC, Engleberg NC: In vivo regulation of replicative Legionella pneumophila lung infection by endogenous tumor necrosis factor alpha and nitric oxide. Infect Immun 1995;63:3253\u20133258.","journal-title":"Infect Immun"},{"key":"BF02786504_CR20","doi-asserted-by":"crossref","first-page":"1633","DOI":"10.4049\/jimmunol.162.3.1633","volume":"162","author":"B Mehrad","year":"1999","unstructured":"Mehrad B, Strieter RM, Standiford TJ: Role of TNF in pulmonary host defense in murine invasive asper-gillosis. J Immunol 1999; 162: 1633\u20131640","journal-title":"J Immunol"},{"key":"BF02786504_CR21","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1165\/ajrcmb\/8.4.370","volume":"8","author":"JK Kolls","year":"1993","unstructured":"Kolls JK, Beck JM, Nelson S, Summer WR, Shellito J: Alveolar macrophage release of tumor necrosis factor during murine Pneumocystis carinii pneumonia. Am J Respir Cell Mol Biol 1993; 8:370\u2013376.","journal-title":"Am J Respir Cell Mol Biol"},{"key":"BF02786504_CR22","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1089\/10430349950018300","volume":"10","author":"TJ Standiford","year":"1999","unstructured":"Standiford TJ, Wilkowski JM, Sisson TH, Hattori N, Mehrad B, Bucknell KA, Moore TA: Intrapulmonary tumor necrosis factor gene therapy increases bacterial clearance and survival in murine gram-negative pneumonia. Hum Gene Ther 1999; 10:899\u2013909","journal-title":"Hum Gene Ther"},{"key":"BF02786504_CR23","doi-asserted-by":"crossref","first-page":"2822","DOI":"10.1128\/IAI.66.6.2822-2826.1998","volume":"66","author":"LL Laichalk","year":"1998","unstructured":"Laichalk LL, Bucknell KA, Huffnagle GB, Wilkowski JM, Moore TA, Romanelli RJ, et al.: Intrapulmonary delivery of tumor necrosis factor agonist peptide augments host defense in murine gram-negative bacterial pneumonia. Infect Immun 1998;66:2822\u20132826.","journal-title":"Infect Immun"},{"key":"BF02786504_CR24","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1002\/jlb.59.1.24","volume":"59","author":"TJ Standiford","year":"1996","unstructured":"Standiford TJ, Kunkel SL, Greenberger MJ, Laichalk LL, Strieter RM: Expression and regulation of chemokines in bacterial pneumonia. J Leukoc Biol 1996; 59:24\u201328.","journal-title":"J Leukoc Biol"},{"key":"BF02786504_CR25","first-page":"151","volume-title":"Chemokines in Disease","author":"GB Huffnagle","year":"1996","unstructured":"Huffnagle GB, Strieter RM, Kunkel SL, Toews GB, Standiford TJ: The role of chemokines in pneumonia; in Koch, A, Strieter, RM (eds): Chemokines in Disease. Austin, R.G.Landes, 1996, pp 151\u2013168."},{"key":"BF02786504_CR26","first-page":"155","volume-title":"The Lung: Scientific Foundations","author":"RM Strieter","year":"1996","unstructured":"Strieter RM, Kunkel SL: Chemokines; in Crystal, RG, West, JB, Weibel, ER, Barnes, PJ (eds): The Lung: Scientific Foundations. Philadelphia, Lippincott-Raven, 1996, pp 155\u2013186."},{"key":"BF02786504_CR27","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1146\/annurev.immunol.15.1.675","volume":"15","author":"M Baggiolini","year":"1997","unstructured":"Baggiolini M, Dewald B, Moser B: Human chemokines: an update. Annu Rev Immunol 1997;15: 675\u2013705.","journal-title":"Annu Rev Immunol"},{"key":"BF02786504_CR28","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1097\/00005373-199207000-00015","volume":"33","author":"JL Rodriguez","year":"1992","unstructured":"Rodriguez JL, Miller CG, DeForge LE, Kelty L, Shanley CJ, Bartlett RH, et al.: Local production of interleukin-8 is associated with nosocomial pneumonia. J Trauma 1992;33:74\u201381; discussion 81\u201372.","journal-title":"J Trauma"},{"key":"BF02786504_CR29","first-page":"1058","volume":"151","author":"TL Benfield","year":"1995","unstructured":"Benfield TL, Vestbo J, Junge J, Nielsen TL, Jensen AB, Lundgren JD: Prognostic value of interleukin-8 in AIDS-associated Pneumocystis carinii pneumonia. Am J Respir Crit Care Med 1995; 151: 1058\u20131062.","journal-title":"Am J Respir Crit Care Med"},{"key":"BF02786504_CR30","doi-asserted-by":"crossref","first-page":"10,853","DOI":"10.1074\/jbc.271.18.10853","volume":"271","author":"MC Johnson","year":"1996","unstructured":"Johnson MC, 2nd, Kajikawa O, Goodman RB, Wong VA, Mongovin SM, Wong WB, et al.: Molecular expression of the alpha-chemokine rabbit GRO inEscherichia coli and characterization of its production by lung cells in vitro and in vivo. J Biol Chem 1996;271: 10,853\u201310,858.","journal-title":"J Biol Chem"},{"key":"BF02786504_CR31","doi-asserted-by":"crossref","first-page":"3164","DOI":"10.1128\/IAI.66.7.3164-3169.1998","volume":"66","author":"K Kooguchi","year":"1998","unstructured":"Kooguchi K, Hashimoto S, Kobayashi A, Kitamura Y, Kudoh I, Wiener-Kronish J, et al.: Role of alveolar macrophages in initiation and regulation of inflammation inPseudomonas aeruginosa pneumonia. Infect Immun 1998;66: 3164\u20133169.","journal-title":"Infect Immun"},{"key":"BF02786504_CR32","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1093\/infdis\/173.1.159","volume":"173","author":"MJ Greenberger","year":"1996","unstructured":"Greenberger MJ, Strieter RM, Kunkel SL, Danforth JM, Laichalk LL, McGillicuddy DC, et al.: Neutralization of macrophage inflammatory protein-2 attenuates neutro-phil recruitment and bacterial clearance in murine Klebsiella pneumonia. J Infect Dis 1996;173:159\u2013165.","journal-title":"J Infect Dis"},{"key":"BF02786504_CR33","doi-asserted-by":"crossref","first-page":"2435","DOI":"10.4049\/jimmunol.161.5.2435","volume":"161","author":"WC Tsai","year":"1998","unstructured":"Tsai WC, Strieter RM, Wilkowski JM, Bucknell KA, Burdick MD, Lira S A, et al.:Lung-specific transgenic expression of KC enhances resistance to Klebsiella pneumoniae in mice. J Immunol 1998; 161:2435\u20132440.","journal-title":"J Immunol"},{"key":"BF02786504_CR34","doi-asserted-by":"crossref","first-page":"1959","DOI":"10.1084\/jem.185.11.1959","volume":"185","author":"JL Gao","year":"1997","unstructured":"Gao JL, Wynn TA, Chang Y, Lee EJ, Broxraeyer HE, Cooper S, et al.: Impaired host defense, hematopoiesis, granulomatous inflammation and type 1 -type 2 cytokine balance in mice lacking CC chemokine receptor 1. J Exp Med 1997; 185:1959\u20131968.","journal-title":"J Exp Med"},{"key":"BF02786504_CR35","doi-asserted-by":"crossref","first-page":"4790","DOI":"10.4049\/jimmunol.155.10.4790","volume":"155","author":"GB Huffnagle","year":"1995","unstructured":"Huffnagle GB, Strieter RM, Standiford TJ, McDonald RA, Burdick MD, et al.: The role of monocyte chemotactic protein-1 (MCP-1) in the recruitment of monocytes and CD4+ T cells during a pulmonaryCryptococcus neoformans infection. J Immunol 1995;155:4790\u20134797.","journal-title":"J Immunol"},{"key":"BF02786504_CR36","doi-asserted-by":"crossref","first-page":"318","DOI":"10.4049\/jimmunol.159.1.318","volume":"159","author":"GB Huffnagle","year":"1997","unstructured":"Huffnagle GB, Strieter RM, McNeil LK, McDonald RA, Burdick MD, Kunkel SL, et al.: Macrophage inflammatory protein-1 alpha (MIP-1 alpha) is required for the efferent phase of pulmonary cell-mediated immunity to a Cryptococcus neoformans infection. J Immunol 1997; 159:318\u2013327.","journal-title":"J Immunol"},{"key":"BF02786504_CR37","doi-asserted-by":"crossref","first-page":"2348","DOI":"10.4049\/jimmunol.136.7.2348","volume":"136","author":"TR Mosmann","year":"1986","unstructured":"Mosmann TR, Cherwinski H, Bond MW, Giedlin MA, Coffman RL: Two types of murine helper T cell clone. I. Definition according to profiles of lymphokine activities and secreted proteins. J Immunol 1986;136:2348\u20132357.","journal-title":"J Immunol"},{"key":"BF02786504_CR38","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1007\/BF01543103","volume":"15","author":"S Romagnani","year":"1995","unstructured":"Romagnani S: Biology of human TH1 and TH2 cells. J Clin Immunol 1995;15:121\u2013129.","journal-title":"J Clin Immunol"},{"key":"BF02786504_CR39","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/S0167-5699(97)01102-X","volume":"18","author":"JE Allen","year":"1997","unstructured":"Allen JE, Maizels RM: Thl-Th2: reliable paradigm or dangerous dogma? Immunol Today 1997;18: 387\u2013392.","journal-title":"Immunol Today"},{"key":"BF02786504_CR40","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/S0065-2776(08)60428-9","volume":"62","author":"A Billiau","year":"1996","unstructured":"Billiau A: Interferon-gamma: biology and role in pathogenesis. Adv Immunol 1996;62:61\u2013130.","journal-title":"Adv Immunol"},{"key":"BF02786504_CR41","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1146\/annurev.immunol.15.1.749","volume":"15","author":"U Boehm","year":"1997","unstructured":"Boehm U, Klamp T, Groot M, Howard JC: Cellular responses to interferon-gamma. Annu Rev Immunol 1997;15:749\u2013795.","journal-title":"Annu Rev Immunol"},{"key":"BF02786504_CR42","doi-asserted-by":"crossref","first-page":"216","DOI":"10.7326\/0003-4819-123-3-199508010-00009","volume":"123","author":"JI Gallin","year":"1995","unstructured":"Gallin JI, Farber JM, Holland SM, Nutman TB: Interferon-gamma in the management of infectious diseases. Ann Intern Med 1995;123: 216\u2013224.","journal-title":"Ann Intern Med"},{"key":"BF02786504_CR43","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1056\/NEJM199102213240801","volume":"324","author":"The International Chronic Granulomatous Disease Cooperative Study Group","year":"1991","unstructured":"The International Chronic Granulomatous Disease Cooperative Study Group. A controlled trial of interferon gamma to prevent infection in chronic granulomatous disease. N Engl J Med 1991;324: 509\u2013516.","journal-title":"N Engl J Med"},{"key":"BF02786504_CR44","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1097\/00000441-199311000-00012","volume":"306","author":"JK Kolls","year":"1993","unstructured":"Kolls JK, Nelson S, Summer WR: Recombinant cytokines and pulmonary host defense. Am J Med Sci 1993;306:330\u2013335.","journal-title":"Am J Med Sci"},{"key":"BF02786504_CR45","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1016\/S0171-2985(11)80458-4","volume":"191","author":"R Appelberg","year":"1994","unstructured":"Appelberg R: Protective role of interferon gamma, tumor necrosis factor alpha and interleukin-6 inMycobacterium tuberculosis andM. avium infections. Immunobiology 1994;191:520\u2013525.","journal-title":"Immunobiology"},{"key":"BF02786504_CR46","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1165\/ajrcmb.13.1.7598935","volume":"13","author":"JA Lovchik","year":"1995","unstructured":"Lovchik JA, Lyons CR, Lipscomb MF: A role for gamma interferoninduced nitric oxide in pulmonary clearance ofCryptococcus neoformans. Am J Respir Cell Mol Biol 1995;13:116\u2013124.","journal-title":"Am J Respir Cell Mol Biol"},{"key":"BF02786504_CR47","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1165\/ajrcmb.13.4.7546779","volume":"13","author":"KA Hoag","year":"1995","unstructured":"Hoag KA, Street NE, Huffnagle GB, Lipscomb MF: Early cytokine production in pulmonaryCryptococcus neoformans infections distinguishes susceptible and resistant mice. Am J Respir Cell Mol Biol 1995;13:487\u2013495.","journal-title":"Am J Respir Cell Mol Biol"},{"key":"BF02786504_CR48","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1128\/IAI.65.2.373-379.1997","volume":"65","author":"BA Garvy","year":"1997","unstructured":"Garvy BA, Ezekowitz RA, Harmsen AG: Role of gamma interferon in the host immune and inflammatory responses toPneumocystis carinii infection. Infect Immun 1997;65:373\u2013379.","journal-title":"Infect Immun"},{"key":"BF02786504_CR49","doi-asserted-by":"crossref","first-page":"3859","DOI":"10.1128\/IAI.59.11.3859-3862.1991","volume":"59","author":"JM Beck","year":"1991","unstructured":"Beck JM, Liggitt HD, Brunette EN, Fuchs HJ, Shellito JE, Debs RJ: Reduction in intensity ofPneumocystis carinii pneumonia in mice by aerosol administration of gamma interferon. Infect Immun 1991;59:3859\u20133862.","journal-title":"Infect Immun"},{"key":"BF02786504_CR50","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1164\/ajrccm.149.1.8111597","volume":"149","author":"SJ Skerrett","year":"1994","unstructured":"Skerrett SJ, Martin TR: Intratracheal interferon-gamma augments pulmonary defenses in experimental legionellosis. Am J Respir Crit Care Med 1994;149:50\u201358.","journal-title":"Am J Respir Crit Care Med"},{"key":"BF02786504_CR51","doi-asserted-by":"crossref","first-page":"1870","DOI":"10.1128\/IAI.65.5.1870-1875.1997","volume":"65","author":"WC Tsai","year":"1997","unstructured":"Tsai WC, Strieter RM, Zisman DA, Wilkowski JM, Bucknell KA, Chen GH, et al.: Nitric oxide is required for effective innate immunity against Klebsiella pneumoniae. Infect Immun 1997; 65: 1870\u20131875.","journal-title":"Infect Immun"},{"key":"BF02786504_CR52","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1111\/j.1530-0277.1998.tb04303.x","volume":"22","author":"DA Zisman","year":"1998","unstructured":"Zisman DA, Strieter RM, Kunkel SL, Tsai WC, Wilkowski JM, Bucknell KA, et al.: Ethanol feeding impairs innate immunity and alters the expression of Thland Th2-phenotype cytokines in murineKlebsiella pneumonia. Alcohol Clin Exp Res 1998;22: 621\u2013627.","journal-title":"Alcohol Clin Exp Res"},{"key":"BF02786504_CR53","doi-asserted-by":"crossref","first-page":"3006","DOI":"10.4049\/jimmunol.157.7.3006","volume":"157","author":"MJ Greenberger","year":"1996","unstructured":"Greenberger MJ, Kunkel SL, Strieter RM, Lukacs NW, Bramson J, Gauldie J, et al.: IL-12 gene therapy protects mice in lethalKlebsiella pneumonia. J Immunol 1996;157:3006\u20133012.","journal-title":"J Immunol"},{"key":"BF02786504_CR54","doi-asserted-by":"crossref","first-page":"2975","DOI":"10.1128\/IAI.65.7.2975-2977.1997","volume":"65","author":"JB Rubins","year":"1997","unstructured":"Rubins JB, Pomeroy C: Role of gamma interferon in the pathogenesis of bacteremic pneumococcal pneumonia. Infect Immun 1997; 65:2975\u20132977.","journal-title":"Infect Immun"},{"key":"BF02786504_CR55","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1046\/j.1365-2249.1996.d01-618.x","volume":"103","author":"HK Johansen","year":"1996","unstructured":"Johansen HK, Hougen HP, Rygaard J, Hoiby N: Interferon-gamma (IFN-gamma) treatment decreases the inflammatory response in chronicPseudomonas aeruginosa pneumonia in rats. Clin Exp Immunol 1996;103:212\u2013218.","journal-title":"Clin Exp Immunol"},{"key":"BF02786504_CR56","doi-asserted-by":"crossref","first-page":"104S","DOI":"10.1378\/chest.111.6_Supplement.104S","volume":"111","author":"JK Kolls","year":"1997","unstructured":"Kolls JK, Lei D, Nelson S, Summer WR, Shellito JE: Pulmonary cytokine gene therapy. Adenoviral -mediated murine interferon gene transfer compartmentally activates alveolar macrophages and enhances bacterial clearance. Chest 1997;111:104S.","journal-title":"Chest"},{"key":"BF02786504_CR57","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1111\/j.1530-0277.1998.tb03632.x","volume":"22","author":"JK Kolls","year":"1998","unstructured":"Kolls JK, Lei D, Stoltz D, Zhang P, Schwarzenberger PO, Ye P, et al:. Adenoviral-mediated interferon -gamma gene therapy augments pulmonary host defense of ethanol-treated rats. Alcohol Clin Exp Res 1998;22:157\u2013162.","journal-title":"Alcohol Clin Exp Res"},{"key":"BF02786504_CR58","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1002\/jlb.59.4.505","volume":"59","author":"G Trinchieri","year":"1996","unstructured":"Trinchieri G, Gerosa F: Immunoregulation by interleukin-12. J LeukocBiol 1996;59:505\u2013511.","journal-title":"J LeukocBiol"},{"key":"BF02786504_CR59","doi-asserted-by":"crossref","first-page":"6115","DOI":"10.1073\/pnas.90.13.6115","volume":"90","author":"RT Gazzinelli","year":"1993","unstructured":"Gazzinelli RT, Hieny S, Wynn TA, Wolf S, Sher A: Interleukin 12 is required for the T-lymphocyte -independent induction of interferon gamma by an intracellular parasite and induces resistance in T cell-deficient hosts [see comments]. Proc Natl Acad Sci USA 1993:90:6115\u20136119.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BF02786504_CR60","doi-asserted-by":"crossref","first-page":"1505","DOI":"10.1084\/jem.177.5.1505","volume":"177","author":"FP Heinzel","year":"1993","unstructured":"Heinzel FP, Schoenhaut DS, Rerko RM, Rosser LE, Gately MK: Recombinant interleukin 12 cures mice infected withLeishmania major. J Exp Med 1993; 177: 1505\u20131509.","journal-title":"J Exp Med"},{"key":"BF02786504_CR61","doi-asserted-by":"crossref","first-page":"2515","DOI":"10.4049\/jimmunol.155.5.2515","volume":"155","author":"JL Flynn","year":"1995","unstructured":"Flynn JL, Goldstein MM, Triebold KJ, Sypek J, Wolf S, Bloom BR: IL-12 increases resistance of BALB\/ c mice toMycobacterium tuberculosis infection. J Immunol 1995; 155:2515\u20132524.","journal-title":"J Immunol"},{"key":"BF02786504_CR62","doi-asserted-by":"crossref","first-page":"2545","DOI":"10.4049\/jimmunol.155.5.2545","volume":"155","author":"MM Stevenson","year":"1995","unstructured":"Stevenson MM, Tam MF, Wolf SF, Sher A: IL-12-induced protection against blood-stage Plasmodium chabaudi AS requires IFN-gamma and TNF-alpha and occurs via a nitric oxide-dependent mechanism. J Immunol 1995 ; 155:2545\u20132556.","journal-title":"J Immunol"},{"key":"BF02786504_CR63","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1006\/mpat.1994.1064","volume":"17","author":"RD Wagner","year":"1994","unstructured":"Wagner RD, Steinberg H, Brown JF, Czuprynski CJ: Recombinant interleukin-12 enhances resistance of mice to Listeria monocytogenes infection. Microb Pathog 1994;17:175\u2013186.","journal-title":"Microb Pathog"},{"key":"BF02786504_CR64","first-page":"423","volume":"84","author":"AM Cooper","year":"1995","unstructured":"Cooper AM, Roberts AD, Rhoades ER, Callahan JE, Getzy DM, Orme IM: The role of interleukin-12 in acquired immunity to Mycobacterium tuberculosis infection. Immunology 1995;84:423\u2013432.","journal-title":"Immunology"},{"key":"BF02786504_CR65","doi-asserted-by":"crossref","first-page":"785","DOI":"10.4049\/jimmunol.155.2.785","volume":"155","author":"P Zhou","year":"1995","unstructured":"Zhou P, Sieve MC, Bennett J, Kwon-Chung KJ, Tewari RP, Gazzinelli RT, et al:. IL-12 prevents mortality in mice infected with Histoplasma capsulatum through induction of IFN-gamma. J Immunol 1995;155:785\u2013795.","journal-title":"J Immunol"},{"key":"BF02786504_CR66","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1046\/j.1365-2249.1996.14723.x","volume":"104","author":"K Kawakami","year":"1996","unstructured":"Kawakami K, Tohyama M, Xie Q, Saito A: IL-12 protects mice against pulmonary and disseminated infection caused byCryptococcus neoformans. Clin Exp Immunol 1996;104:208\u2013214.","journal-title":"Clin Exp Immunol"},{"key":"BF02786504_CR67","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1128\/CMR.10.4.611","volume":"10","author":"L Romani","year":"1997","unstructured":"Romani L, Puccetti P, Bistoni F: Interleukin-12 in infectious diseases. Clin Microbiol Rev 1997; 10:611\u2013636.","journal-title":"Clin Microbiol Rev"},{"key":"BF02786504_CR68","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1111\/j.1574-695X.1996.tb00084.x","volume":"15","author":"LL Laichalk","year":"1996","unstructured":"Laichalk LL, Danforth JM, Standiford TJ: Interleukin-10 inhibits neutrophil phagocytic and bactericidal activity. FEMS Immunol Med Microbiol 1996; 15:181\u2013187.","journal-title":"FEMS Immunol Med Microbiol"},{"key":"BF02786504_CR69","doi-asserted-by":"crossref","first-page":"808","DOI":"10.4049\/jimmunol.148.3.808","volume":"148","author":"P Ralph","year":"1992","unstructured":"Ralph P, Nakoinz I, Sampson-Johannes A, Fong S, Lowe D, et al.: IL-10, T lymphocyte inhibitor of human blood cell production of IL-1 and tumor necrosis factor. J Immunol 1992;148:808\u2013814.","journal-title":"J Immunol"},{"key":"BF02786504_CR70","doi-asserted-by":"crossref","first-page":"2207","DOI":"10.1084\/jem.178.6.2207","volume":"178","author":"MA Cassatella","year":"1993","unstructured":"Cassatella MA, Meda L, Bonora S, Ceska M, Constantin G: Interleukin 10 (IL-10) inhibits the release of proinflammatory cytokines from human polymorphonuclear leukocytes. Evidence for an autocrine role of tumor necrosis factor and IL-1 beta in mediating the production of IL-8 triggered by lipopolysaccharide. J Exp Med 1993;178:2207\u20132211.","journal-title":"J Exp Med"},{"key":"BF02786504_CR71","doi-asserted-by":"crossref","first-page":"3559","DOI":"10.4049\/jimmunol.152.7.3559","volume":"152","author":"T Kasama","year":"1994","unstructured":"Kasama T, Strieter RM, Lukacs NW, Burdick MD, Kunkel SL: Regulation of neutrophil-derived chemokine expression by IL-10. J Immunol 1994;152:3559\u20133569.","journal-title":"J Immunol"},{"key":"BF02786504_CR72","doi-asserted-by":"crossref","first-page":"537","DOI":"10.3109\/07853899509002465","volume":"27","author":"JE Vries de","year":"1995","unstructured":"de Vries JE: Immunosuppressive and anti-inflammatory properties of interleukin 10. Ann Med 1995; 27:537\u2013541.","journal-title":"Ann Med"},{"key":"BF02786504_CR73","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1084\/jem.177.4.1205","volume":"177","author":"M Howard","year":"1993","unstructured":"Howard M, Muchamuel T, Andrade S, Menon S: Interleukin 10 protects mice from lethal endotoxemia. J Exp Med 1993;177:1205\u20131208.","journal-title":"J Exp Med"},{"key":"BF02786504_CR74","doi-asserted-by":"crossref","first-page":"2222","DOI":"10.4049\/jimmunol.155.4.2222","volume":"155","author":"TJ Standiford","year":"1995","unstructured":"Standiford TJ, Strieter RM, Lukacs NW, Kunkel SL: Neutralization of IL-10 increases lethality in endotoxemia. Cooperative effects of macrophage inflammatory protein-2 and tumor necrosis factor. J Immunol 1995;155:2222\u20132229.","journal-title":"J Immunol"},{"key":"BF02786504_CR75","first-page":"L566","volume":"271","author":"G Cox","year":"1996","unstructured":"Cox G: IL-10 enhances resolution of pulmonary inflammation in vivo by promoting apoptosis of neutrophils. Am J Physiol 1996; 271:L566\u2013571.","journal-title":"Am J Physiol"},{"key":"BF02786504_CR76","doi-asserted-by":"crossref","first-page":"5666","DOI":"10.4049\/jimmunol.151.10.5666","volume":"151","author":"MS Mulligan","year":"1993","unstructured":"Mulligan MS, Jones ML, Vaporciyan AA, Howard MC, Ward PA: Protective effects of IL-4 and IL-10 against immune complex-induced lung injury. J Immunol 1993;151:5666\u20135674.","journal-title":"J Immunol"},{"key":"BF02786504_CR77","doi-asserted-by":"crossref","first-page":"722","DOI":"10.4049\/jimmunol.155.2.722","volume":"155","author":"MJ Greenberger","year":"1995","unstructured":"Greenberger MJ, Strieter RM, Kunkel SL, Danforth JM, Goodman RE, Standiford TJ: Neutralization of IL-10 increases survival in a murine model ofKlebsiella pneumonia. J Immunol 1995;155:722\u2013729.","journal-title":"J Immunol"},{"key":"BF02786504_CR78","doi-asserted-by":"crossref","first-page":"994","DOI":"10.1093\/infdis\/174.5.994","volume":"174","author":"T Poll van der","year":"1996","unstructured":"van der Poll T, Marchant A, Keogh CV, Goldman M, Lowry SF: Interleukin-10 impairs host defense in murine pneumococcal pneumonia. J Infect Dis 1996;174:994\u20131000.","journal-title":"J Infect Dis"},{"key":"BF02786504_CR79","doi-asserted-by":"crossref","first-page":"2846","DOI":"10.1128\/IAI.64.7.2846-2849.1996","volume":"64","author":"A Vecchiarelli","year":"1996","unstructured":"Vecchiarelli A, Retini C, Monari C, Tascini C, Bistoni F, Kozel TR: Purified capsular poly saccharide ofCryptococcus neoformans induces interleukin-10 secretion by human monocytes. Infect Immun 1996; 64:2846\u20132849.","journal-title":"Infect Immun"},{"key":"BF02786504_CR80","doi-asserted-by":"crossref","first-page":"4338","DOI":"10.4049\/jimmunol.156.11.4338","volume":"156","author":"X Yang","year":"1996","unstructured":"Yang X, HayGlass KT, Brunham RC: Genetically determined differences in IL-10 and IFN-gamma responses correlate with clearance of Chlamydia trachomatis mouse pneumonitis infection. J Immunol 1996;156:4338\u20134344.","journal-title":"J Immunol"},{"key":"BF02786504_CR81","doi-asserted-by":"crossref","first-page":"3093","DOI":"10.1128\/IAI.61.7.3093-3097.1993","volume":"61","author":"LE Bermudez","year":"1993","unstructured":"Bermudez LE, Champsi J: Infection withMycobacterium avium induces production of interleukin-10 (IL-10), and administration of anti-IL-10 antibody is associated with enhanced resistance to infection in mice. Infect Immun 1993; 61:3093\u20133097.","journal-title":"Infect Immun"},{"key":"BF02786504_CR82","doi-asserted-by":"crossref","first-page":"392","DOI":"10.4049\/jimmunol.162.1.392","volume":"162","author":"ML Steinhauser","year":"1999","unstructured":"Steinhauser ML, Hogaboam CM, Kunkel SL, Lukacs NW, Strieter RM, Standiford TJ: Interleukin 10 is a major mediator of sepsisinduced impairment in lung antimicrobial host defense. J Immunol 1999;162:392\u2013399.","journal-title":"J Immunol"},{"key":"BF02786504_CR83","doi-asserted-by":"crossref","first-page":"2858","DOI":"10.4049\/jimmunol.159.6.2858","volume":"159","author":"T Sawa","year":"1997","unstructured":"Sawa T, Corry DB, Gropper MA, Ohara M, Kurahashi K, Wiener-Kronish JP: IL-10 improves lung injury and survival in Pseudomonas aeruginosa pneumonia. J Immunol 1997;159:2858\u20132866.","journal-title":"J Immunol"},{"key":"BF02786504_CR84","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1159\/000109193","volume":"5","author":"GB Huffnagle","year":"1996","unstructured":"Huffnagle GB: Role of cytokines in T cell immunity to a pulmonaryCryptococcus neoformans infection. Biol Signals 1996;5:215\u2013222.","journal-title":"Biol Signals"},{"key":"BF02786504_CR85","doi-asserted-by":"crossref","first-page":"2393","DOI":"10.4049\/jimmunol.160.5.2393","volume":"160","author":"GB Huffnagle","year":"1998","unstructured":"Huffnagle GB, Boyd MB, Street NE, Lipscomb MF: IL-5 is required for eosinophil recruitment, crystal deposition, and mononuclear cell recruitment during a pulmonaryCryptococcus neoformans infection in genetically susceptible mice (C57BL\/6). J Immunol 1998; 160: 2393\u20132400.","journal-title":"J Immunol"},{"key":"BF02786504_CR86","doi-asserted-by":"crossref","first-page":"3037","DOI":"10.1128\/IAI.63.8.3037-3041.1995","volume":"63","author":"ST Kanaly","year":"1995","unstructured":"Kanaly ST, Hines SA, Palmer GH: Cytokine modulation alters pulmonary clearance of Rhodococcus equi and development of granulomatous pneumonia. Infect Immun 1995;63:3037\u20133041.","journal-title":"Infect Immun"},{"key":"BF02786504_CR87","doi-asserted-by":"crossref","first-page":"4229","DOI":"10.1128\/IAI.66.9.4229-4236.1998","volume":"66","author":"S Jain-Vora","year":"1998","unstructured":"Jain-Vora S, LeVine AM, Chroneos Z, Ross GF, Hull WM, Whitsett JA: Interleukin-4 enhances pulmonary clearance ofPseudomonas aeruginosa. Infect Immun 1998;66:4229\u20134236.","journal-title":"Infect Immun"},{"key":"BF02786504_CR88","doi-asserted-by":"crossref","first-page":"127","DOI":"10.7326\/0003-4819-128-2-199801150-00009","volume":"128","author":"DA Papanicolaou","year":"1998","unstructured":"Papanicolaou DA, Wilder RL, Manolagas SC, Chrousos GP: The pathophysiologic roles of interleukin-6 in human disease. Ann Intern Med 1998;128:127\u2013137.","journal-title":"Ann Intern Med"},{"key":"BF02786504_CR89","first-page":"l","volume":"54","author":"S Akira","year":"1993","unstructured":"Akira S, Taga T, Kishimoto T: Interleukin-6 in biology and medicine. Adv Immunol 1993;54:l-78.","journal-title":"Adv Immunol"},{"key":"BF02786504_CR90","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1038\/368339a0","volume":"368","author":"M Kopf","year":"1994","unstructured":"Kopf M, Baumann H, Freer G, Freudenberg M, Lamers M, Kishimoto T, et al.: Impaired immune and acute-phase responses in interleukin-6-deficient mice. Nature 1994;368:339\u2013342.","journal-title":"Nature"},{"key":"BF02786504_CR91","doi-asserted-by":"crossref","first-page":"1704","DOI":"10.1182\/blood.V74.5.1704.1704","volume":"74","author":"CE Hack","year":"1989","unstructured":"Hack CE, De Groot ER, Felt-Bersma RJ, Nuijens JH, Strack Van Schijndel RJ, et al.: Increased plasma levels of interleukin-6 in sepsis [see comments]. Blood 1989; 74:1704\u20131710.","journal-title":"Blood"},{"key":"BF02786504_CR92","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1164\/ajrccm.156.4.9610002","volume":"156","author":"MJ Bonten","year":"1997","unstructured":"Bonten MJ, Froon AH, Gaillard CA, Greve JW, de Leeuw PW, Drent M, et al.: The systemic inflammatory response in the development of ventilator-associated pneumonia. Am J Respir Crit Care Med 1997; 156:1105\u20131113.","journal-title":"Am J Respir Crit Care Med"},{"key":"BF02786504_CR93","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1007\/BF02113582","volume":"25","author":"D Lieberman","year":"1997","unstructured":"Lieberman D, Livnat S, Schlaeffer F, Porath A, Horowitz S, Levy R: IL-1 beta and IL-6 in community-acquired pneumonia: bacteremic pneumococcal pneumonia versusMycoplasma pneumoniae pneumonia. Infection 1997;25:90\u201394.","journal-title":"Infection"},{"key":"BF02786504_CR94","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1542\/peds.93.1.54","volume":"93","author":"C Buck","year":"1994","unstructured":"Buck C, Bundschu J, Gallati H, Bartmann P, Pohlandt F: Inter-leukin-6: a sensitive parameter for the early diagnosis of neonatal bacterial infection. Pediatrics 1994; 93:54\u201358.","journal-title":"Pediatrics"},{"key":"BF02786504_CR95","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1016\/S0140-6736(98)08148-3","volume":"352","author":"H Kuster","year":"1998","unstructured":"Kuster H, Weiss M, Willeitner AE, Detlefsen S, Jeremias I, Zbojan J, et al.: Interleukin-1 receptor antagonist and interleukin-6 for early diagnosis of neonatal sepsis 2 days before clinical manifestation [in process citation]. Lancet 1998; 352:1271\u20131277.","journal-title":"Lancet"},{"key":"BF02786504_CR96","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1172\/JCI1368","volume":"101","author":"Z Xing","year":"1998","unstructured":"Xing Z, Gauldie J, Cox G, Baumann H, Jordana M, Lei XF, Achong MK: IL-6 is an antiinflammatory cytokine required for controlling local or systemic acute inflammatory responses. J Clin Invest 1998; 101:311\u2013320.","journal-title":"J Clin Invest"},{"key":"BF02786504_CR97","doi-asserted-by":"crossref","first-page":"2262","DOI":"10.1128\/IAI.63.6.2262-2268.1995","volume":"63","author":"SA Dalrymple","year":"1995","unstructured":"Dalrymple SA, Lucian LA, Slattery R, McNeil T, Aud DM, Fuchino S, et al.: Interleukin-6-deficient mice are highly susceptible to Listeria monocytogenes infection: correlation with inefficient neutrophilia. Infect Immun 1995; 63:2262\u20132268.","journal-title":"Infect Immun"},{"key":"BF02786504_CR98","doi-asserted-by":"crossref","first-page":"3231","DOI":"10.1128\/IAI.64.8.3231-3235.1996","volume":"64","author":"SA Dalrymple","year":"1996","unstructured":"Dalrymple SA, Slattery R, Aud DM, Krishna M, Lucian LA, Murray R: Interleukin-6 is required for a protective immune response to systemic Escherichia coli infection. Infect Immun 1996;64:3231\u20133235.","journal-title":"Infect Immun"},{"key":"BF02786504_CR99","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1086\/514062","volume":"176","author":"T Poll van der","year":"1997","unstructured":"van der Poll T, Keogh CV, Guirao X, Buurman WA, Kopf M, Lowry SF: Interleukin-6 gene-deficient mice show impaired defense against pneumococcal pneumonia. J Infect Dis 1997; 176:439\u2013444.","journal-title":"J Infect Dis"},{"issue":"2","key":"BF02786504_CR100","doi-asserted-by":"crossref","first-page":"S197","DOI":"10.1093\/clinids\/18.Supplement_2.S197","volume":"18","author":"S Nelson","year":"1994","unstructured":"Nelson S: Role of granulocyte colony-stimulating factor in the immune response to acute bacterial infection in the nonneutropenic host: an overview. Clin Infect Dis 1994;18 Suppl 2:S197\u2013204.","journal-title":"Clin Infect Dis"},{"key":"BF02786504_CR101","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1111\/j.1365-2141.1994.tb05015.x","volume":"88","author":"K Pauksen","year":"1994","unstructured":"Pauksen K, Elfman L, Ulfgren AK, Venge P: Serum levels of granulocyte-colony stimulating factor (G-CSF) in bacterial and viral infections, and in atypical pneumonia. Br J Haematol 1994; 88:256\u2013260.","journal-title":"Br J Haematol"},{"key":"BF02786504_CR102","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1165\/ajrcmb\/4.2.140","volume":"4","author":"A Tazi","year":"1991","unstructured":"Tazi A, Nioche S, Chastre J, Smiejan JM, Hance AJ: Spontaneous release of granulocyte colonystimulating factor (G-CSF) by alveolar macrophages in the course of bacterial pneumonia and sarcoidosis: endotoxin-dependent and endotoxin-independent G-CSF release by cells recovered by bronchoal veolar lavage. Am J Respir Cell Mol Biol 1991;4:140\u2013147.","journal-title":"Am J Respir Cell Mol Biol"},{"key":"BF02786504_CR103","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1002\/jlb.48.1.67","volume":"48","author":"LE Bermudez","year":"1990","unstructured":"Bermudez LE, Young LS: Recombinant granulocyte-macrophage colony-stimulating factor activates human macrophages to inhibit growth or killMycobacterium avium complex. J Leukoc Biol 1990;48:67\u201373.","journal-title":"J Leukoc Biol"},{"key":"BF02786504_CR104","first-page":"2396","volume":"59","author":"DK Blanchard","year":"1991","unstructured":"Blanchard DK, Michelini-Norris MB, Pearson CA, McMillen S, Djeu JY: Production of granulocyte -macrophage colony-stimulating factor (GM-CSF) by monocytes and large granular lymphocytes stimulated with Mycobacterium avium-M. intracellulare: activation of bactericidal activity by GM-CSF. Infectlmmun 1991;59:2396\u20132402.","journal-title":"Infectlmmun"},{"key":"BF02786504_CR105","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1002\/jlb.49.4.380","volume":"49","author":"M Denis","year":"1991","unstructured":"Denis M: Tumor necrosis factor and granulocyte macrophage-colony stimulating factor stimulate human macrophages to restrict growth of virulent Mycobacterium avium and to kill avirulentM. avium: killing effector mechanism depends on the generation of reactive nitrogen intermediates. J Leukoc Biol 1991 ; 49:380\u2013387.","journal-title":"J Leukoc Biol"},{"key":"BF02786504_CR106","doi-asserted-by":"crossref","first-page":"724","DOI":"10.4049\/jimmunol.152.2.724","volume":"152","author":"GH Chen","year":"1994","unstructured":"Chen GH, Curtis JL, Mody CH, Christensen PJ, Armstrong LR, Toews GB: Effect of granulocytemacrophage colony-stimulating factor on rat alveolar macrophage anticryptococcal activity in vitro. J Immunol 1994; 152:724\u2013734.","journal-title":"J Immunol"},{"key":"BF02786504_CR107","first-page":"3393","volume":"59","author":"SM Levitz","year":"1991","unstructured":"Levitz SM: Activation of human peripheral blood mononuclear cells by interleukin-2 and granulocytemacrophage colony-stimulating factor to inhibitCryptococcus neoformans. InfectImmun 1991;59: 3393\u20133397.","journal-title":"InfectImmun"},{"key":"BF02786504_CR108","first-page":"663","volume":"41","author":"JC Hebert","year":"1996","unstructured":"Hebert JC, O\u2019Reilly M: Granulocyte -macrophage colony-stimulating factor (GM-CSF) enhances pulmonary defenses against pneumococcal infections after splenectomy. JTrauma 1996;41:663\u2013666.","journal-title":"JTrauma"},{"key":"BF02786504_CR109","first-page":"1233","volume":"151","author":"IF Mandujano","year":"1995","unstructured":"Mandujano IF, D\u2019Souza NB, Nelson S, Summer WR, Beckerman RC, Shellito JE: Granulocyte-macrophage colony stimulating factor and Pneumocystis carinii pneumonia in mice. Am J Respir Crit Care Med 1995;151:1233\u20131238.","journal-title":"Am J Respir Crit Care Med"},{"key":"BF02786504_CR110","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1093\/infdis\/168.4.922","volume":"168","author":"PD Lister","year":"1993","unstructured":"Lister PD, Gentry MJ, Preheim LC: Granulocyte colony-stimulating factor protects control rats but not ethanol-fed rats from fatal pneumococcal pneumonia. J Infect Dis 1993;168:922\u2013926.","journal-title":"J Infect Dis"},{"key":"BF02786504_CR111","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1093\/infdis\/174.1.225","volume":"174","author":"LC Preheim","year":"1996","unstructured":"Preheim LC, Snitily MU, Gentry MJ: Effects of granulocyte colony-stimulating factor in cirrhotic rats with pneumococcal pneumonia. J Infect Dis 1996; 174:225\u2013228.","journal-title":"J Infect Dis"},{"key":"BF02786504_CR112","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1093\/infdis\/164.5.901","volume":"164","author":"S Nelson","year":"1991","unstructured":"Nelson S, Summer W, Bagby G, Nakamura C, Stewart L, Lipscomb G, et al.: Granulocyte colony-stimulating factor enhances pulmonary host defenses in normal and ethanol-treated rats. J Infect Dis 1991; 164:901\u2013906.","journal-title":"J Infect Dis"},{"key":"BF02786504_CR113","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1182\/blood.V86.4.1301.bloodjournal8641301","volume":"86","author":"WS Smith","year":"1995","unstructured":"Smith WS, Sumnicht GE, Sharpe RW, Samuelson D, Millard FE: Granulocyte colony-stimulating factor versus placebo in addition to penicillin G in a randomized blinded study of gram-negative pneumonia sepsis: analysis of survival and multisystem organ failure. Blood 1995;86:1301\u20131309.","journal-title":"Blood"},{"key":"BF02786504_CR114","doi-asserted-by":"crossref","first-page":"1467","DOI":"10.1152\/jappl.1997.83.5.1467","volume":"83","author":"BD Freeman","year":"1997","unstructured":"Freeman BD, Quezado Z, Zeni F, Natanson C, Danner RL, Banks S, et al.: rG-CSF reduces endotoxemia and improves survival during E. coli pneumonia. J Appl Physiol 1997;83:1467\u20131475.","journal-title":"J Appl Physiol"},{"key":"BF02786504_CR115","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1086\/515694","volume":"178","author":"S Nelson","year":"1998","unstructured":"Nelson S, Belknap SM, Carlson RW, Dale D, DeBoisblanc B, Farkas S, et al.: A randomized controlled trial of filgrastim as an adjunct to antibiotics for treatment of hospitalized patients with community-acquired pneumonia. CAP Study Group. J Infect Dis 1998; 178: 1075\u20131080.","journal-title":"J Infect Dis"}],"container-title":["Immunologic Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF02786504.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/BF02786504\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF02786504","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,15]],"date-time":"2023-05-15T10:54:25Z","timestamp":1684148065000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/BF02786504"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1999,8]]},"references-count":115,"journal-issue":{"issue":"1","published-print":{"date-parts":[[1999,8]]}},"alternative-id":["BF02786504"],"URL":"https:\/\/doi.org\/10.1007\/bf02786504","relation":{},"ISSN":["0257-277X","1559-0755"],"issn-type":[{"value":"0257-277X","type":"print"},{"value":"1559-0755","type":"electronic"}],"subject":[],"published":{"date-parts":[[1999,8]]}}}